3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
7
Tumor-Agnostic
5
CNS
5
Head & Neck
2
Sarcoma
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Ovarian Neoplasms
15
Uterine Cervical Neoplasms
12
Carcinoma, Ovarian Epithelial
10
Fallopian Tube Neoplasms
8
Endometrial Neoplasms
7
Peritoneal Neoplasms
4
Colorectal Neoplasms
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Recurrence
2
Uterine Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Shoulder Impingement Syndrome
1
Sarcoma
1
Pregnancy Complications
1
Postoperative Complications
1
Pelvic Neoplasms
1
Patient Satisfaction
1
Pain, Postoperative
1
Ovarian Germ Cell Cancer
1
Ovarian Cysts
1
Neoplasms
1
Neoplasm Metastasis
1
Myofibroma
1
Mesothelioma, Malignant
1
Mesothelioma
1
Leiomyoma
1
Infertility, Female
1
Interventions
Paclitaxel
28
Carboplatin
28
pembrolizumab
25
Bevacizumab
14
liposomal doxorubicin
12
Cisplatin
11
Gemcitabine
10
Radiotherapy
8
Drug Therapy
8
Cyclophosphamide
8
Blood Specimen Collection
8
Topotecan
7
Nivolumab
7
olaparib
6
Doxorubicin
6
niraparib
5
Therapeutics
5
Dexamethasone
5
pertuzumab
4
pazopanib
4
lenvatinib
4
fludarabine
4
cemiplimab
4
atezolizumab
4
Trastuzumab
4
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Fulvestrant
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Surgical Procedures, Operative
×
Gynecologic
×
Clear all
NCT04586959
2025-10-15
MAN-U
Baylor College of Medicine
Phase NA
Recruiting
278 enrolled